XML 58 R8.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted shares
Restricted stock units
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Restricted shares
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted shares
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Non-controlling interests in consolidated entities
Beginning balance (in shares) at Dec. 31, 2022             224,310,000                
Balances at beginning of period at Dec. 31, 2022 $ 9,030.2     $ 8,839.5     $ 44.9     $ 437.9     $ 8,409.7 $ (53.0) $ 190.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,385.1     1,351.1                 1,351.1   34.0
Other comprehensive income (loss), net of tax 6.8     6.8                   6.8  
Dividends declared (841.1)     (841.1)                 (841.1)    
Shares issued upon option exercises (in shares)             486,000                
Shares issued upon option exercises 28.5     28.5     $ 0.1     28.4          
Restricted shares issued, net of shares withheld for taxes (in shares)               57,000              
Net shares issued upon vesting of restricted stock units (in shares)                 85,000            
Net shares issued upon vesting of restricted stock units     $ (3.2)     $ (3.2)           $ (3.2)      
Stock-based compensation expense 169.7     169.7           169.7          
Restricted stock units issued as dividend equivalents 0.0                 0.3     (0.3)    
Common shares repurchased (in shares)             (1,398,000)                
Common shares repurchased (151.4)     (151.4)     $ (0.3)     (151.1)          
Net distributions to non-controlling interests in consolidated entities (3.2)                           (3.2)
Ending balance (in shares) at Sep. 30, 2023             223,540,000                
Balances at end of period at Sep. 30, 2023 9,621.4     9,399.9     $ 44.7     482.0     8,919.4 (46.2) 221.5
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2022 656.7                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 11.0                            
Other comprehensive income (loss), net of tax 7.7                            
Net subscriptions into T. Rowe Price investment products 345.0                            
Net deconsolidations of T. Rowe Price investment products (460.2)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2023 560.2                            
Beginning balance (in shares) at Jun. 30, 2023             224,281,000                
Balances at beginning of period at Jun. 30, 2023 9,465.9     9,263.8     $ 44.8     520.6     8,746.2 (47.8) 202.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 473.1     453.2                 453.2   19.9
Other comprehensive income (loss), net of tax 1.6     1.6                   1.6  
Dividends declared (279.9)     (279.9)                 (279.9)    
Shares issued upon option exercises (in shares)             227,000                
Shares issued upon option exercises 13.6     13.6     $ 0.1     13.5          
Restricted shares issued, net of shares withheld for taxes (in shares)               3,000              
Net shares issued upon vesting of restricted stock units (in shares)                 7,000            
Net shares issued upon vesting of restricted stock units     (0.4)     (0.4)           (0.4)      
Stock-based compensation expense 54.2     54.2           54.2          
Restricted stock units issued as dividend equivalents 0.0                 0.1     (0.1)    
Common shares repurchased (in shares)             (978,000)                
Common shares repurchased (106.2)     (106.2)     $ (0.2)     (106.0)          
Net distributions to non-controlling interests in consolidated entities (0.5)                           (0.5)
Ending balance (in shares) at Sep. 30, 2023             223,540,000                
Balances at end of period at Sep. 30, 2023 9,621.4     9,399.9     $ 44.7     482.0     8,919.4 (46.2) 221.5
Beginning balances attributable to redeemable non-controlling interests at Jun. 30, 2023 985.2                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) (14.0)                            
Other comprehensive income (loss), net of tax (3.9)                            
Net subscriptions into T. Rowe Price investment products 59.0                            
Net deconsolidations of T. Rowe Price investment products (466.1)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2023 560.2                            
Beginning balance (in shares) at Dec. 31, 2023             223,938,000                
Balances at beginning of period at Dec. 31, 2023 9,697.1     9,505.1     $ 44.8     431.7     9,076.1 (47.5) 192.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,669.0     1,660.2                 1,660.2   8.8
Other comprehensive income (loss), net of tax 8.0     8.0                   8.0  
Dividends declared $ (850.7)     (850.7)                 (850.7)    
Shares issued upon option exercises (in shares) 683,555           482,000                
Shares issued upon option exercises $ 30.5     30.5     $ 0.1     30.4          
Restricted shares issued, net of shares withheld for taxes (in shares)               7,000              
Restricted shares issued, net of shares withheld for taxes   $ (0.3)     $ (0.3)           $ (0.3)        
Net shares issued upon vesting of restricted stock units (in shares)                 64,000            
Net shares issued upon vesting of restricted stock units     (2.0)     (2.0)           (2.0)      
Stock-based compensation expense 162.2     162.2           162.2          
Restricted stock units issued as dividend equivalents 0.0                 0.3     (0.3)    
Common shares repurchased (in shares)             (2,348,000)                
Common shares repurchased (263.7)     (263.7)     $ (0.5)     (263.2)          
Net contributions to non-controlling interests in consolidated entities 2.6                           2.6
Ending balance (in shares) at Sep. 30, 2024             222,143,000                
Balances at end of period at Sep. 30, 2024 10,452.7     10,249.3     $ 44.4     359.1     9,885.3 (39.5) 203.4
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2023 594.1                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 58.9                            
Other comprehensive income (loss), net of tax 6.2                            
Net subscriptions into T. Rowe Price investment products 361.0                            
Net deconsolidations of T. Rowe Price investment products (256.8)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2024 763.4                            
Beginning balance (in shares) at Jun. 30, 2024             222,612,000                
Balances at beginning of period at Jun. 30, 2024 10,134.0     9,928.7     $ 44.5     368.8     9,564.6 (49.2) 205.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 601.0     603.0                 603.0   (2.0)
Other comprehensive income (loss), net of tax 9.7     9.7                   9.7  
Dividends declared (282.2)     (282.2)                 (282.2)    
Shares issued upon option exercises (in shares)             187,000                
Shares issued upon option exercises 12.1     12.1           12.1          
Net shares issued upon vesting of restricted stock units (in shares)                 8,000            
Net shares issued upon vesting of restricted stock units     $ (0.2)     $ (0.2)           $ (0.2)      
Stock-based compensation expense 49.5     49.5           49.5          
Restricted stock units issued as dividend equivalents 0.0                 0.1     (0.1)    
Common shares repurchased (in shares)             (664,000)                
Common shares repurchased (71.3)     (71.3)     $ (0.1)     (71.2)          
Net contributions to non-controlling interests in consolidated entities 0.1                           0.1
Ending balance (in shares) at Sep. 30, 2024             222,143,000                
Balances at end of period at Sep. 30, 2024 10,452.7     $ 10,249.3     $ 44.4     $ 359.1     $ 9,885.3 $ (39.5) $ 203.4
Beginning balances attributable to redeemable non-controlling interests at Jun. 30, 2024 689.0                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 37.4                            
Other comprehensive income (loss), net of tax 7.4                            
Net subscriptions into T. Rowe Price investment products 190.2                            
Net deconsolidations of T. Rowe Price investment products (160.6)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2024 $ 763.4                            
[1] Accumulated other comprehensive income